Benoit FORGET Date of Birth: January 29 1979.
2003-2007: Ph. D. of Neurosciences Completed on July 6, 2007 (Marie-Helene Thiebot,
supervisor). Pierre et Marie Curie University (Paris VI, UPMC), France. UMR 677 INSERM/UPMC
Neuropsychopharmacology (Michel Hamon, Head).
2002-2003: Master of Neurosciences Pierre et Marie Curie University (Paris VI, UPMC), France.
2001-2002: Master of Psychopharmacology of Cognitive Processes. Bordeaux I University, France.
– 2010-now: Postdoctoral fellow in the laboratory of “Neurobiologie Intégrative des Systèmes Cholinergiques” (Dr Uwe Maskos, Head), URA CNRS 2182, Institut Pasteur, Paris, France.
– 2007-2010: Postdoctoral fellow in the Translational Addiction Research Laboratory (Dr. Bernard LeFoll, Head) Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Canada M5S 2S1.
Le Foll B, Pushparaj A, Pryslawsky Y, Forget B, Vemuri K, Makriyannis A, Trigo JM (2013) Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach. Progress in neuro-psychopharmacology & biological psychiatry.
Pushparaj A, Pryslawsky Y, Forget B, Yan Y, Le Foll B (2012) Extinction bursts in rats trained to self-administer nicotine or food in 1-h daily sessions. Am J Transl Res. 4(4):422-31
Benoit Forget, Wertheim C, Mascia P, Pushparaj A, Goldberg SR, Le Foll B (2010a) Noradrenergic α1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology Jul;35(8):1751-60.
Benoit Forget, Pushparaj A, Le Foll B (2010b) Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biological Psychiatry 68(3):265-71.
Benoit Forget, Kathy Coen and Bernard LeFoll (2009a) Inhibition of fatty acid amid hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration – Comparison with CB1 receptor blockade. Psychopharmacology (Berl) 205(4):613-24.
Forget B, Hamon M, Thiébot MH (2009b) Involvement of α-1 adrenoceptors in motivational effects of nicotine in rats. Psychopharmacology (Berl) (Berl) 205: 503-15
Scherma M, Fadda P, Le Foll B, Forget B, Fratta W, Goldberg SR, et al (2008). The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. CNS Neurol Disord Drug Targets 7(5): 468-481.
Le Foll B, Forget B, Aubin HJ, Goldberg SR (2008) Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies. Addict Biol 13: 239-52
Forget B, Barthélémy S, Saurini F, Hamon M, Thiébot MH (2006) differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Psychopharmacology (Berl) 189 (1): 59-69
Forget B, Hamon M, Thiébot MH (2005) Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 181: 722-34